Bahn Andrew, Ljubojevic Marija, Lorenz Heiko, Schultz Christian, Ghebremedhin Estifanos, Ugele Bernhard, Sabolic Ivan, Burckhardt Gerhard, Hagos Yohannes
Zentrum für Physiologie und Pathophysiologie, Abt. Vegetative Physiologie und Pathophysiologie, Universität Göttingen, Humboldtallee 23, D-37073 Göttingen, Germany.
Am J Physiol Cell Physiol. 2005 Nov;289(5):C1075-84. doi: 10.1152/ajpcell.00619.2004. Epub 2005 Jun 8.
Tryptophan metabolites such as kynurenate (KYNA), xanthurenate (XA), and quinolinate are considered to have an important impact on many physiological processes, especially brain function. Many of these metabolites are secreted with the urine. Because organic anion transporters (OATs) facilitate the renal secretion of weak organic acids, we investigated whether the secretion of bioactive tryptophan metabolites is mediated by OAT1 and OAT3, two prominent members of the OAT family. Immunohistochemical analyses of the mouse kidneys revealed the expression of OAT1 to be restricted to the proximal convoluted tubule (representing S1 and S2 segments), whereas OAT3 was detected in almost all parts of the nephron, including macula densa cells. In the mouse brain, OAT1 was found to be expressed in neurons of the cortex cerebri and hippocampus as well as in the ependymal cell layer of the choroid plexus. Six tryptophan metabolites, including the bioactive substances KYNA, XA, and the serotonin metabolite 5-hydroxyindol acetate inhibited [(3)H]p-aminohippurate (PAH) or 6-carboxyfluorescein (6-CF) uptake by 50-85%, demonstrating that these compounds interact with OAT1 as well as with OAT3. Half-maximal inhibition of mOAT1 occurred at 34 muM KYNA and 15 muM XA, and it occurred at 8 muM KYNA and 11.5 muM XA for mOAT3. Quinolinate showed a slight but significant inhibition of [(3)H]PAH uptake by mOAT1 and no alteration of 6-CF uptake by mOAT3. [(14)C]-Glutarate (GA) uptake was examined for both transporters and demonstrated differences in the transport rate for this substrate by a factor of 4. Trans-stimulation experiments with GA revealed that KYNA and XA are substrates for mOAT1. Our results support the idea that OAT1 and OAT3 are involved in the secretion of bioactive tryptophan metabolites from the body. Consequently, they are crucial for the regulation of central nervous system tryptophan metabolite concentration.
色氨酸代谢产物,如犬尿喹啉酸(KYNA)、黄尿酸(XA)和喹啉酸,被认为对许多生理过程,尤其是脑功能有重要影响。这些代谢产物中的许多都随尿液分泌。由于有机阴离子转运体(OATs)促进弱有机酸的肾脏分泌,我们研究了具有生物活性的色氨酸代谢产物的分泌是否由OAT家族的两个主要成员OAT1和OAT3介导。对小鼠肾脏的免疫组织化学分析显示,OAT1的表达仅限于近端曲管(代表S1和S2段),而OAT3在肾单位的几乎所有部位都有检测到,包括致密斑细胞。在小鼠脑中,发现OAT1在大脑皮层和海马的神经元以及脉络丛的室管膜细胞层中表达。六种色氨酸代谢产物,包括生物活性物质KYNA、XA和血清素代谢产物5-羟基吲哚乙酸,抑制[³H]对氨基马尿酸(PAH)或6-羧基荧光素(6-CF)摄取达50%-85%,表明这些化合物与OAT1以及OAT3相互作用。mOAT1的半数最大抑制浓度在34 μM KYNA和15 μM XA时出现,mOAT3则在8 μM KYNA和11.5 μM XA时出现。喹啉酸对mOAT1摄取[³H]PAH有轻微但显著的抑制作用,对mOAT3摄取6-CF无影响。对两种转运体都检测了[¹⁴C] - 戊二酸(GA)的摄取,结果表明该底物的转运速率相差4倍。用GA进行的反式刺激实验表明,KYNA和XA是mOAT1的底物。我们的结果支持OAT1和OAT3参与生物活性色氨酸代谢产物从体内分泌的观点。因此,它们对于调节中枢神经系统色氨酸代谢产物浓度至关重要。